Cargando…

Genetic determinants of methotrexate treatment efficacy in patients with juvenile idiopathic arthritis

Detalles Bibliográficos
Autores principales: Avramovič, Mojca Zajc, Toplak, Nataša, Accetto, Meta, Debeljak, Maruša, Lusa, Lara, Dolžan, Vita, Avčin, Tadej
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4184211/
http://dx.doi.org/10.1186/1546-0096-12-S1-P26
_version_ 1782337807301214208
author Avramovič, Mojca Zajc
Toplak, Nataša
Accetto, Meta
Debeljak, Maruša
Lusa, Lara
Dolžan, Vita
Avčin, Tadej
author_facet Avramovič, Mojca Zajc
Toplak, Nataša
Accetto, Meta
Debeljak, Maruša
Lusa, Lara
Dolžan, Vita
Avčin, Tadej
author_sort Avramovič, Mojca Zajc
collection PubMed
description
format Online
Article
Text
id pubmed-4184211
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-41842112014-10-30 Genetic determinants of methotrexate treatment efficacy in patients with juvenile idiopathic arthritis Avramovič, Mojca Zajc Toplak, Nataša Accetto, Meta Debeljak, Maruša Lusa, Lara Dolžan, Vita Avčin, Tadej Pediatr Rheumatol Online J Poster Presentation BioMed Central 2014-09-17 /pmc/articles/PMC4184211/ http://dx.doi.org/10.1186/1546-0096-12-S1-P26 Text en Copyright © 2014 Avramovič et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/4.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Poster Presentation
Avramovič, Mojca Zajc
Toplak, Nataša
Accetto, Meta
Debeljak, Maruša
Lusa, Lara
Dolžan, Vita
Avčin, Tadej
Genetic determinants of methotrexate treatment efficacy in patients with juvenile idiopathic arthritis
title Genetic determinants of methotrexate treatment efficacy in patients with juvenile idiopathic arthritis
title_full Genetic determinants of methotrexate treatment efficacy in patients with juvenile idiopathic arthritis
title_fullStr Genetic determinants of methotrexate treatment efficacy in patients with juvenile idiopathic arthritis
title_full_unstemmed Genetic determinants of methotrexate treatment efficacy in patients with juvenile idiopathic arthritis
title_short Genetic determinants of methotrexate treatment efficacy in patients with juvenile idiopathic arthritis
title_sort genetic determinants of methotrexate treatment efficacy in patients with juvenile idiopathic arthritis
topic Poster Presentation
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4184211/
http://dx.doi.org/10.1186/1546-0096-12-S1-P26
work_keys_str_mv AT avramovicmojcazajc geneticdeterminantsofmethotrexatetreatmentefficacyinpatientswithjuvenileidiopathicarthritis
AT toplaknatasa geneticdeterminantsofmethotrexatetreatmentefficacyinpatientswithjuvenileidiopathicarthritis
AT accettometa geneticdeterminantsofmethotrexatetreatmentefficacyinpatientswithjuvenileidiopathicarthritis
AT debeljakmarusa geneticdeterminantsofmethotrexatetreatmentefficacyinpatientswithjuvenileidiopathicarthritis
AT lusalara geneticdeterminantsofmethotrexatetreatmentefficacyinpatientswithjuvenileidiopathicarthritis
AT dolzanvita geneticdeterminantsofmethotrexatetreatmentefficacyinpatientswithjuvenileidiopathicarthritis
AT avcintadej geneticdeterminantsofmethotrexatetreatmentefficacyinpatientswithjuvenileidiopathicarthritis